diabetes

These 2 European Pharmas Grabbed Upgrades Ahead Of 2018 News
Investors Business Daily
Tue, 01/2/18 - 11:42 am
Europe
AstraZeneca
Lynparza
ovarian cancer
Novo Nordisk
diabetes
semaglutide
Merck, Pfizer make a late — very late — arrival at the SGLT2 party for diabetes
Endpoints
Thu, 12/21/17 - 10:07 am
Merck
Pfizer
SGLT2 inhibitor
diabetes
tugliflozin
Study: Most commonly-prescribed diabetes drug linked to lowest rate of compliance
Drug Delivery Business News
Mon, 12/18/17 - 10:16 am
diabetes
patients
metformin
patient adherence
Mylan Announces IPR Proceedings for Sanofi's Lantus Patents
Yahoo/Zacks.com
Fri, 12/15/17 - 11:45 pm
Mylan Labs
inter partes review
Sanofi
Lantus
patents
diabetes
FDA approves Sanofi’s short-acting insulin lispro injection
Drug Delivery Business News
Mon, 12/11/17 - 11:22 pm
FDA
Sanofi
insulin
Admelog insulin lispro
diabetes
Lilly launches trial for automated insulin delivery system
Drug Delivery Business News
Tue, 12/5/17 - 11:09 am
Eli Lilly
automated insulin delivery
insulin
diabetes
devices
Connected Diabetes Ecosystem
Sanofi touts head-to-head comparison of long-acting insulin products
Drug Delivery Business News
Mon, 12/4/17 - 11:48 am
Sanofi
insulin
diabetes
Toujeo
long-acting insulin
Novo Nordisk
Tresiba
J&J, Lilly and AZ diabetes medications get another helping of real-world heart benefits
Fierce Pharma
Fri, 11/24/17 - 09:23 am
JNJ
Eli Lilly
AstraZeneca
Boehringer Ingelheim
diabetes
Invokana
Farxiga
Jardiance
Lilly used nursing services as kickbacks to boost insulin prescriptions, lawsuit claims
Fierce Pharma
Thu, 11/16/17 - 07:18 pm
Eli Lilly
diabetes
nurses
insulin
kickbacks
Blue Cross Plans Partner With Alphabet Venture To Manage Diabetes
Forbes
Thu, 11/16/17 - 11:15 am
Blue Cross
Alphabet
diabetes
blood glucose monitoring
Onduo
wearables
devices
Cost of diabetes epidemic reaches $850 billion a year
Yahoo/Reuters
Tue, 11/14/17 - 07:45 am
diabetes
type 2 diabetes
Study: Glytec’s diabetes management tech improves care for patients leaving the hospital
Drug Delivery Business News
Mon, 11/13/17 - 10:33 am
Glytec
diabetes
devices
eGlycemic diabetes management system
Nevada Scares Diabetes Drug Manufacturers With Halloween List of “Essential Diabetes Drugs”
FDA Law Blog
Thu, 11/9/17 - 12:01 pm
Nevada
diabetes
Diabetes industry keeps deteriorating: Sanofi and Novo announce declining sales (Q3 2017)
GoinPharma
Sat, 11/4/17 - 08:42 am
Sanofi
Novo Nordisk
diabetes
Novo Nordisk shares slip on cautious guidance, insulin pricing concerns
Drug Delivery Business News
Wed, 11/1/17 - 10:02 am
Novo Nordisk
earnings
diabetes
insulin
drug pricing
In a strategic switch, Sumitomo Dainippon bags rights to a PhIII diabetes drug from Poxel in $300M deal
Endpoints
Mon, 10/30/17 - 11:05 am
Sumitomo Dainippon
diabetes
clinical trials
imeglimin
Poxel
Sanofi sues Mylan over Lantus patents, seeking to defend its top-selling drug
Fierce Pharma
Wed, 10/25/17 - 11:58 am
Sanofi
Mylan Labs
Lantus
patents
insulin
biosimilars
diabetes
FDA clears AstraZeneca’s once-weekly Type II diabetes drug-device combo
Drug Delivery Business News
Mon, 10/23/17 - 10:01 am
AstraZeneca
FDA
diabetes
drug-device combos
Bydureon
With FDA panel backing, Novo Nordisk prepares for semaglutide's potential launch
Fierce Biotech
Thu, 10/19/17 - 12:00 pm
FDA
Novo Nordisk
semaglutide
diabetes
Novo's experimental diabetes drug likely to compete with Trulicity
Medical Marketing and Media
Tue, 10/17/17 - 08:29 pm
Novo Nordisk
diabetes
Trulicity
semaglutide

Pages